相关实验视频

Updated: May 16, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1,2,3-triazole杂交物具有抗癌治疗潜力的当前景观:第二部分

Zhi Xu¹, Junna Liu²

¹Huanghuai University Industry Innovation & Research and Development Institute, Huanghuai University, Zhumadian, Henan, China.

Archiv der Pharmazie

|April 2, 2025

概括

1,2,3-醇杂交物显示出作为新型抗癌剂的希望,有效地准多种癌症途径并克服耐药性. 这篇评论探讨了它们在癌症治疗中的潜力,强调了最近的进展.

科学领域:

药用化学医学化学
在瘤学瘤学.
药物发现药物发现药物发现

背景情况:

化疗对于癌症治疗至关重要,但面临着诸如多药物耐药性和严重副作用等挑战.
对于能够准癌症中的多个生物途径的新型治疗药物有着至关重要的需求.
1,2,3-triazole杂交物正在成为开发新抗癌药物的有希望的支架.

研究的目的:

为了提供一个全面的概述的1,2,3-triazole混合物作为抗癌药物.
讨论这些化合物的体外和体外抗癌潜力.
分析1,2,3-triazole杂交物的结构-活性关系和作用机制.

主要方法:

从2021年开始发表的科学文章的文献综述.
对报告1,2,3-triazole杂交物的合成和生物评估的研究分析.
检查结构-活动关系和建议的行动机制.

主要成果:

1,2,3-三醇混合物显示出对癌细胞的双重/多重点参与的显著潜力.
这些化合物具有强大的广泛抗癌活性,包括对抗耐药癌症类型的有效性.
最近的研究突出了通过这些混合体施加细胞毒性作用的多种机制.

结论:

1,2,3-二醇混合物代表了开发下一代癌症治疗药物的宝贵支架.
它们的多目标能力为克服癌症治疗当前局限性提供了一个有希望的策略.
对1,2,3-triazole杂交物的进一步研究是有必要的,以充分利用它们的治疗潜力.

关键词:

一,二,三-二醇是什么癌症癌症癌症癌症癌症混合物混合物混合物行动机制的行动机制.结构活动关系结构活动关系

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...